298 results on '"Amata, Emanuele"'
Search Results
2. Nanostructured lipid carrier for the ophthalmic delivery of haloperidol metabolite II valproate ester (±)-MRJF22: A potential strategy in the treatment of uveal melanoma
3. Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors
4. Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects
5. Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation
6. Exploring Structural Requirements for Sigma‑1 Receptor Linear Ligands: Experimental and Computational Approaches.
7. Designing drugs optimized for both blood–brain barrier permeation and intra-cerebral partition
8. Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors
9. [1]Benzothieno[3,2-d]pyrimidine derivatives as ligands for the serotonergic 5-HT7 receptor
10. Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity
11. Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines
12. Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors
13. Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents
14. Heme oxygenase-1: A new druggable target in the management of chronic and acute myeloid leukemia
15. Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain
16. New Insights into the Opioid Analgesic Profile of cis-(−)-N-Normetazocine-derived Ligands
17. Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands
18. Designing drugs optimized for both blood–brain barrier permeation and intra-cerebral partition
19. Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands
20. Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review
21. Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis
22. Cytotoxicity Profiles and Neuroprotective Properties of the Novel Ifenprodil Analogues as Sigma Ligands
23. Design, synthesis, in vitro evaluation, and molecular modeling studies of N ‐substituted benzomorphans, analogs of LP2 , as novel MOR ligands
24. S2RSLDB: a comprehensive manually curated, internet-accessible database of the sigma-2 receptor selective ligands
25. Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity.
26. In vitro and in silico analysis of imatinib analogues as anti-Trypanosoma cruzi drug candidates
27. Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands
28. H2S releasing molecules in pharmaceutical development
29. Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain
30. Correction to “Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents”
31. Molecular modeling studies of pseudouridine isoxazolidinyl nucleoside analogues as potential inhibitors of the pseudouridine 5’‐monophosphate glycosidase
32. Discovery of 3‐(2‐aminoethyl)‐thiazolidine‐2,4‐diones as a novel chemotype of sigma‐1 receptor ligands
33. MOR/DOR Dual-Target Approach: 2S-LP2 Effects in Inflammatory and Neuropathic Pain
34. Hybrid MOR agonist/HDACi molecules as potential antinociceptive multi-target drugs: design, synthesis, and biological evaluation
35. Design, synthesis, and biological evaluation of new hybrid MOR agonist/HDACi compounds: an innovative approach for persistent pain management
36. Dual Piperidine-Based Histamine H3and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain
37. Synthesis and pharmacological evaluation of indole-based sigma receptor ligands
38. Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties
39. Evaluation of N-substitution in 6,7-benzomorphan compounds
40. Haloperidol Metabolite II Valproate Ester (S)-(−)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma
41. Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents
42. Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity
43. Interaction of new sigma ligands with biomembrane models evaluated by differential scanning calorimetry and Langmuir-Blodgett studies
44. Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinityElectronic supplementary information (ESI) available: (a) Synthetic procedure for preparing compound 1; (b) protocol validation of computational studies. See DOI: https://doi.org/10.1039/d3md00291h
45. Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation
46. Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as Potent Sigma-1 Receptor Antagonist
47. Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists
48. Tuning Properties for Blood–Brain Barrier Permeation: A Statistics-Based Analysis
49. Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma‑1 Receptor Antagonists with Promising Antinociceptive Properties.
50. Synthesis of 'no-light activated' Ciprofloxacin and Norfloxacin derivatives as potential biofilm dispersant agents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.